Annual report pursuant to Section 13 and 15(d)

NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details)

v3.5.0.2
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details)
 12 Months Ended
Aug. 01, 2015
USD ($)
Oct. 01, 2014
USD ($)
May 31, 2016
USD ($)
shares
May 31, 2015
USD ($)
Jul. 20, 2016
USD ($)
Feb. 29, 2016
ft²
a
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Allocated Share-based Compensation Expense     $ 327,500 $ 37,500    
Chief Executive Officer [Member]            
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Employment Agreement, Term   5 years        
Officers' Compensation   $ 150,000 150,000      
Deferred Compensation Arrangement with Individual, Description   performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)        
Share-based Compensation Arrangement by Share-based Payment Award, Description   annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million        
Due to Officers or Stockholders, Current     $ 250,000 106,250    
Chief Operating Officer [Member]            
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Employment Agreement, Term 5 years          
Officers' Compensation $ 150,000          
Deferred Compensation Arrangement with Individual, Description performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)          
Share-based Compensation Arrangement by Share-based Payment Award, Description annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million          
Chief Operating Officer [Member] | One Time Signing Bonus [Member]            
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares     250,000      
Allocated Share-based Compensation Expense     $ 327,500      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     1 year      
Former Officer [Member]            
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Due to Officers or Stockholders, Current     $ 16,290      
Building [Member] | Affiliated Entity [Member]            
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Area of Real Estate Property (in Square Feet) | ft²           42,392
Area of Land (in Acres) | a           1.92
Operating Leases, Rent Expense     $ 177,844 $ 0    
Convertible Notes Payable [Member] | Chief Executive Officer [Member] | Subsequent Event [Member]            
NOTE 15 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]            
Debt Instrument, Face Amount         $ 250,000